United States Central Venous Catheters Market Outlook to 2023

2017-08-01
Price :
Published : Aug-2017
No. of Pages : 68
Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Central Venous Catheters Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Central Venous Catheters Market, United States 7
3.1 Central Venous Catheters Market, United States, Revenue ($m), 2009-2016 7
3.2 Central Venous Catheters Market, United States, Revenue ($m), 2016-2023 9
3.3 Central Venous Catheters Market, United States, Volume (Units), 2009-2016 11
3.4 Central Venous Catheters Market, United States, Volume (Units), 2016-2023 13
3.5 Central Venous Catheters Market, United States, Average Price ($), 2009-2023 15
3.6 Central Venous Catheters Market, United States, Distribution Share by Revenue ($m), 2015-2016 16
3.7 Central Venous Catheters Market, United States, Company Share by Revenue ($m), 2016 17
4 Overview of Key Companies in United States, Central Venous Catheters Market 19
4.1 Teleflex Inc 19
4.1.1 Company Overview 19
4.2 C. R. Bard Inc 19
4.2.1 Company Overview 19
4.3 Edwards Lifesciences Corp 19
4.3.1 Company Overview 19
4.4 B. Braun Melsungen AG 20
4.4.1 Company Overview 20
4.5 Smiths Medical 20
4.5.1 Company Overview 20
5 Central Venous Catheters Market Pipeline Products 21
6 Financial Deals Landscape 22
6.1 Debt Offerings 22
6.1.1 PAVmed Raises USD5 Million in Private Placement of Notes and Warrants 22
6.1.2 Becton, Dickinson to Raise USD725 Million in Public Offering of 2.133% Notes Due 2019 23
6.1.3 Becton, Dickinson to Raise USD1 Billion in Public Offering of 2.404% Notes Due 2020 24
6.1.4 Becton, Dickinson to Raise USD1.8 Billion in Public Offering of 2.894% Notes Due 2022 25
6.1.5 Becton, Dickinson to Raise USD500 Million in Public Offering of Floating Rate Notes Due 2022 26
6.1.6 Becton, Dickinson to Raise USD1.75 Billion in Public Offering of 3.363% Notes Due 2024 27
6.1.7 Becton, Dickinson to Raise USD2.4 Billion in Public Offering of 3.7% Notes Due 2027 28
6.1.8 Becton, Dickinson to Raise USD1.5 Billion in Public Offering of 4.669% Notes Due 2047 29
6.1.9 Becton, Dickinson to Raise USD788 Million in Public Offering of 0.368% Notes Due 2019 30
6.1.10 Becton Dickinson Prices Public Offering of 1% Notes Due 2022 for USD500 Million 31
6.1.11 Becton Dickinson Prices Public Offering of 1.9% Notes Due 2026 for USD500 Million 33
6.2 Equity Offerings 35
6.2.1 Becton Dickinson Raises USD2.47 Billion in Public Offering of Shares 35
6.2.2 Becton Dickinson Raises USD2.47 Billion in Public Offering of Depositary Shares 37
6.2.3 PAVmed to Raise USD10.4 Million in Private Placement of Shares upon Exercise of Warrants 39
6.2.4 PAVmed Raises Additional Funds in Second and Final Tranche of Private Placement of Units 40
6.2.5 PAVmed Raises USD1.5 Million in First Tranche of Private Placement of Units 41
6.2.6 PAVmed to Raise USD5.3 Million in Private Placement of Shares upon Exercise of Warrants 42
7 Recent Developments 43
7.1 Corporate Communications 43
7.1.1 Apr 23, 2017: BD Announces Appointment Of Tom Polen As President 43
7.1.2 Mar 21, 2017: PAVmed Names Medical Device Industry Veteran Dennis M. McGrath as Chief Financial Officer 43
7.1.3 Feb 23, 2017: Teleflex Announces Benson Smith to Retire as Chief Executive Officer at End of 2017; Liam Kelly to Succeed Smith as Chief Executive Officer 44
7.1.4 Jul 28, 2016: BD Names R. Andrew Eckert To Board Of Directors 44
7.2 Financial Announcements 45
7.2.1 May 22, 2017: PAVmed Reports First Quarter 2017 Financial Results and Provides Business Update 45
7.2.2 May 10, 2017: ICU Medical Announces First Quarter 2017 Results 45
7.2.3 May 04, 2017: Teleflex Reports First Quarter 2017 Results 46
7.2.4 May 02, 2017: BD Announces Results For 2017 Second Fiscal Quarter 47
7.2.5 Apr 03, 2017: Retractable Technologies Reports Results for the Year 2016 49
7.2.6 Mar 01, 2017: ICU Medical Announces Fourth Quarter and Fiscal Year 2016 Results 49
7.2.7 Feb 23, 2017: Teleflex Reports Fourth Quarter and Full Year 2016 Results; Provides 2017 Guidance 50
7.2.8 Feb 02, 2017: BD Announces Results For 2017 First Fiscal Quarter 51
7.2.9 Nov 14, 2016: Retractable Technologies Reports Results as of September 30, 2016 52
7.2.10 Nov 09, 2016: ICU Medical Announces Third Quarter 2016 Results 53
7.2.11 Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance 54
7.2.12 Oct 27, 2016: Teleflex Reports Third Quarter 2016 Results 55
7.2.13 Aug 16, 2016: PAVmed Announces Second Quarter 2016 Financial Results and Provides Business Update 57
7.2.14 Aug 16, 2016: Retractable Technologies Reports Results as of June 30, 2016 58
7.2.15 Aug 08, 2016: ICU Medical Announces Second Quarter 2016 Results 59
7.2.16 Aug 04, 2016: BD Announces Results For 2016 Third Fiscal Quarter 59
7.2.17 Jul 28, 2016: Teleflex Reports Second Quarter 2016 Results 61
7.3 Government and Public Interest 62
7.3.1 Jun 06, 2017: BD Releases 2016 Sustainability Report 62
7.3.2 Mar 28, 2017: BD Announces Success of Helping Build Healthy Communities Program, Launches New Effort Focused on Medication Therapy Management 62
7.4 Legal And Regulatory 63
7.4.1 Mar 21, 2017: Retractable Technologies Announces Litigation Updates 63
7.4.2 Dec 02, 2016: Retractable Technologies Reports on Fifth Circuit's Opinion 63
8 Appendix 64
8.1 Research Methodology 65
8.1.1 Coverage 65
8.1.2 Secondary Research 65
8.1.3 Primary Research 66
8.1.4 Company Share Analysis 66
8.1.5 Distribution Share Analysis 66
8.1.6 Benchmarking 67
8.2 GlobalData Consulting 67
8.3 Contact Us 68
8.4 Disclaimer 68

1.1 List of Tables
Table 1: Central Venous Catheters Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 8
Table 2: Central Venous Catheters Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 10
Table 3: Central Venous Catheters Market, United States, Volume (Units), Historic, 2009-2016 12
Table 4: Central Venous Catheters Market, United States, Volume (Units), Forecast, 2016-2023 14
Table 5: Central Venous Catheters Market, United States, Average Price ($), Historic, 2009-2016 15
Table 6: Central Venous Catheters Market, United States, Average Price ($), Forecast, 2016-2023 15
Table 7: Central Venous Catheters Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016 16
Table 8: Central Venous Catheters Market, United States, Company Share by Revenue ($m), USD Constant, 2016 18
Table 9: Central Venous Catheters Market Pipeline Products 21
Table 10: PAVmed Raises USD5 Million in Private Placement of Notes and Warrants 22
Table 11: Becton, Dickinson to Raise USD725 Million in Public Offering of 2.133% Notes Due 2019 23
Table 12: Becton, Dickinson to Raise USD1 Billion in Public Offering of 2.404% Notes Due 2020 24
Table 13: Becton, Dickinson to Raise USD1.8 Billion in Public Offering of 2.894% Notes Due 2022 25
Table 14: Becton, Dickinson to Raise USD500 Million in Public Offering of Floating Rate Notes Due 2022 26
Table 15: Becton, Dickinson to Raise USD1.75 Billion in Public Offering of 3.363% Notes Due 2024 27
Table 16: Becton, Dickinson to Raise USD2.4 Billion in Public Offering of 3.7% Notes Due 2027 28
Table 17: Becton, Dickinson to Raise USD1.5 Billion in Public Offering of 4.669% Notes Due 2047 29
Table 18: Becton, Dickinson to Raise USD788 Million in Public Offering of 0.368% Notes Due 2019 30
Table 19: Becton Dickinson Prices Public Offering of 1% Notes Due 2022 for USD500 Million 31
Table 20: Becton Dickinson Prices Public Offering of 1.9% Notes Due 2026 for USD500 Million 33
Table 21: Becton Dickinson Raises USD2.47 Billion in Public Offering of Shares 35
Table 22: Becton Dickinson Raises USD2.47 Billion in Public Offering of Depositary Shares 37
Table 23: PAVmed to Raise USD10.4 Million in Private Placement of Shares upon Exercise of Warrants 39
Table 24: PAVmed Raises Additional Funds in Second and Final Tranche of Private Placement of Units 40
Table 25: PAVmed Raises USD1.5 Million in First Tranche of Private Placement of Units 41
Table 26: PAVmed to Raise USD5.3 Million in Private Placement of Shares upon Exercise of Warrants 42

1.2 List of Figures
Figure 1: Central Venous Catheters Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 7
Figure 2: Central Venous Catheters Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 9
Figure 3: Central Venous Catheters Market, United States, Volume (Units), Historic, 2009-2016 11
Figure 4: Central Venous Catheters Market, United States, Volume (Units), Forecast, 2016-2023 13
Figure 5: Central Venous Catheters Market, United States, Company Share (%) 2016 17
Filed in: Medical Device, Orthopedic Devices
Publisher : GlobalData